Page 231 - Liver Diseases in Children

โรคภูมิต้านทานต่อตับตนเอง 221

pthaigastro.org
4. Wang P, Su H, Underhill J, Blackmore LJ, Longhi MS, Grammatikopoulos T, et al. Autoantibody and
human leukocyte antigen profiles in children with autoimmune liver disease and their first-degree relatives.

J Pediatr Gastroenterol Nutr 2014;58:457-62.
5. Meloni A, Willcox N, Meager A, Atzeni M, Wolff AS, Husebye ES, et al. Autoimmune polyendocrine
syndrome type 1: an extensive longitudinal study in Sardinian patients. J Clin Endocrinol Metab
2012;97:1114-24.
6. Della Corte C, Sartorelli MR, Sindoni CD, Girolami E, Giovannelli L, Comparcola D, et al. Autoimmune
hepatitis in children: an overview of the disease focusing on current therapies. Eur J Gastroenterol
Hepatol 2012;24:739-46.
7. Gregorio GV, Portmann B, Reid F, Donaldson PT, Doherty DG, McCartney M, et al. Autoimmune
hepatitis in childhood: a 20-year experience. Hepatology 1997;25:541-7.

8. Liberal R, Grant CR, Longhi MS, Mieli-Vergani G, Vergani D. Diagnostic criteria of autoimmune
hepatitis. Autoimmun Rev 2014;13:435-40.
9. Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the
diagnosis of autoimmune hepatitis. Hepatology 2008;48:169-76.
10. Mieli-Vergani G, Vergani D. Paediatric autoimmune liver disease. Arch Dis Child 2013;98:1012-7.
11. Miethke AG, Balistreri WF. Sclerosing cholangitis. In: Suchy FJ, Sokol RJ, Balistreri WF, editors. Liver
disease in children. 4th ed. Cambridge: Cambridge University Press; 2014. p. 322-40.
12. Vergani D, Mieli-Vergani G. Pharmacological management of autoimmune hepatitis. Expert Opin
Pharmacother 2011;12:607-13.
13. Ferreira AR, Roquete ML, Toppa NH, de Castro LP, Fagundes ED, Penna FJ. Effect of treatment of
hepatic histopathology in children and adolescents with autoimmune hepatitis. J Pediatr Gastroenterol

Nutr 2008;46:65-70.
14. Liberal R, Vergani D, Mieli-Vergani G. Recurrence of autoimmune liver disease and inflammatory
bowel disease after pediatric liver transplantation. Liver Transpl 2016;22:1275-83.
15. Mieli-Vergani G, Vergani D, Baumann U, Czubkowski P, Debray D, Dezsofi A, et al. Diagnosis and
management of pediatric autoimmune liver disease: ESPGHAN Hepatology Committee Position
Statement. J Pediatr Gastroenterol Nutr 2018;66:345-60.
16. Cho JM, Kim KM, Oh SH, Lee YJ, Rhee KW, Yu E. De novo autoimmune hepatitis in Korean children
after liver transplantation: a single institution’s experience. Transplant Proc 2011;43:2394-6.
17. Venick RS, McDiarmid SV, Farmer DG, Gornbein J, Martin MG, Vargas JH, et al. Rejection and steroid

dependence: unique risk factors in the development of pediatric posttransplant de novo autoimmune
hepatitis. Am J Transplant 2007;7:955-63.
18. Evans HM, Kelly DA, McKiernan PJ, Hubscher S. Progressive histological damage in liver allografts
following pediatric liver transplantation. Hepatology 2006;43:1109-17.